openPR Logo
Press release

Ophthalmic Drugs Market is Expanding Significantly, Globally (2017-2023) : AMR Report

04-03-2019 02:26 PM CET | Health & Medicine

Press release from: Allied Market Research

Ophthalmic Drugs Market

Ophthalmic Drugs Market

The Global ophthalmic drugs market was valued at $29,613 million in 2016, and is projected to reach $42,663 million by 2023, growing at a CAGR of 5.3% from 2017 to 2023. The Retinal disorders segment accounted for 26.6% of the global ophthalmic drugs market in 2016.

Ophthalmic drugs are extensively used to treat glaucoma, cataract, diabetic retinopathy, and other ophthalmic disorders. Introduction of novel ocular drug delivery approaches in the market has driven the manufacturers to develop innovative therapeutic approaches for the treatment of ophthalmic disorders. According to the American Academy of Ophthalmology, 11 million people in the U.S. suffer from age-related macular degeneration (AMD), while approximately 10% of them are inflicted with wet AMD. Such trends in ophthalmic disorders across the globe contribute to the growth of the market.

Download Sample Report @ https://www.alliedmarketresearch.com/request-sample/310?utm_source=opr_sank

Ophthalmic Drugs Market Key Findings:

• The liquid ophthalmic drug forms generated the highest revenue in 2016, and are anticipated to continue the same trend, registering a CAGR of 4.1% from 2017 to 2023.
• The cell therapy technologies registered significant growth rate and is expected to register a CAGR of 6.5%.
• North America dominated the market, accounting for maximum share of 36% of the total market in 2016 and is expected to witness a CAGR of 4.4%.
• The online pharmacies segment is witnessing the highest CAGR of 5.8% among the end users.
• Anti-inflammatory drugs accounted for two-sevenths share of the global ophthalmic drugs market in 2016.

The other key factors that boost the ophthalmic drug market size include high prevalence of glaucoma worldwide and rise in transition towards development of combination therapies for the treatment of glaucoma. In addition, the dynamics in the demographics across the globe contribute to the market growth. However, risk of side effects associated with ophthalmic drugs and the longer timelines required for novel ophthalmic drugs hamper this growth. Moreover, increase in investment by market players in emerging economies offers lucrative opportunities for market growth in near future.

Indication Segment Review:

The ophthalmic drugs industry is segmented based on indication into dry eye, glaucoma, infection/inflammation/allergy, retinal disorders, and others. The retinal disorders segment is further classified into wet age-related macular degeneration, dry age-related macular degeneration, diabetic retinopathy, and others. Retinal disorders indication has registered significant growth rate, registering a CAGR of 5.8% from 2017 to 2023. The dry age-related macular degeneration segment accounts for the highest share among all the retinal disorders in 2016, and is expected to continue this trend throughout the forecast period.

For More Info on Ophthalmic Drugs Market visit @ https://www.prnewswire.com/news-releases/global-ophthalmic-drugs-market-expected-to-reach-42663-million-by-2023---allied-market-research-657703433.html

Dosage Form Segment Review:

The ophthalmic drugs industry analysis is segmented based on dosage form into liquid, solid, semisolid, multicompartment drug delivery systems, and other ophthalmic drug forms. Liquid ophthalmic drug form segment accounted for the highest revenue in 2016, and is projected to maintain the trend throughout the forecast period. However, multicompartment drug delivery systems registered the highest CAGR of 8.0%. This is attributed to increase in development of novel ocular drug delivery approaches including nanoparticles, noisome, and dendrimers.

Based on geography, the market is divided into North America, Europe, Asia-Pacific, and LAMEA. North America dominates the global market, accounting for 36% of the total market share in 2016, and is anticipated to lead throughout the forecast period. The report provides a comprehensive analysis of the key players operating in the global market such as Santen Pharmaceutical Co., Ltd., Bausch & Lomb Inc. (Valeant Pharmaceuticals International, Inc.), Shire Plc, Alcon (Novartis), Genentech, Inc. Allergan, Plc, Sun Pharmaceutical Industries Limited, Actavis Generics (Teva Pharmaceutical Industries Ltd.), Regeneron Pharmaceuticals, Inc., and Pfizer Inc.

The other key players in the value chain include Abbott Medical Optics, Inc., Carl-Zeiss AG, Ellex Medical Lasers Ltd., Essilor International S.A., Hoya Corporation, Insight Vision Inc., Nidek Co.Ltd, Novagali Pharma S A, Topcon Corporation, and Ziemer Ophthalmic Systems AG.

Ophthalmic Drugs Market Key Benefits:

• The study provides an in-depth analysis with the current trends and future estimations of the global ophthalmic drugs market to elucidate the imminent investment pockets.
• Comprehensive analysis of the factors that drive and restrict the market growth is provided.
• The quantitative analysis of the industry from 2016 to 2023 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
• Extensive analysis of key segments of the industry is provided to understand the type of ophthalmic drugs used globally.
• Key players and their strategies are analyzed to understand the competitive outlook of the market.

Flat 20% Discount on All License Type.. https://www.alliedmarketresearch.com/checkout/494210?utm_source=opr_sank
*Offer Valid Till 20th April 2019

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client's insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ophthalmic Drugs Market is Expanding Significantly, Globally (2017-2023) : AMR Report here

News-ID: 1685940 • Views: 187

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for Ophthalmic

Ophthalmic Eye Shield Market Segmentation By Material type Aluminium Ophthalmic …
Eye shields are advised for use in the eye while a periorbital surgery to avoid any injury to the globe. Ophthalmic eye shields are used for postoperative ocular protection. Ophthalmic eye shields protect the cornea and retina while any eye surgery or laser treatment. Ophthalmic eye shields are highly preferred for cataract surgeries in the elder population and blepharitis correction especially for children. According to WHO, The World Health Organization,
Global Ophthalmic Devices Market Size And Segments
The Business Research Company’s global ophthalmic devices market report, covers the year-on-year growth of the global Ophthalmic Devices market historic and forecast growth. It also includes chapters on the ophthalmic devices market trends, ophthalmic devices market size, ophthalmic devices market geographical analysis, ophthalmic devices market driver and restraints, and ophthalmic devices market leading competitors’ revenues, profiles and market shares. Order The Global Ophthalmic Devices Market Report At: https://www.thebusinessresearchcompany.com/report/ophthalmic-devices-global-market-report Global Ophthalmic Devices Market Segments The
Ophthalmic Viscosurgical Devices Market Snapshot During 2025
The global ophthalmic viscosurgical devices market is driven by the growing number of cataract procedures held worldwide. In addition to this, the lack of awareness among people regarding the need for regular eye checkups will also heighten the demand for ophthalmic viscosurgical devices in the future. The tendency to procrastinate eye checkups and thus, delayed detection of eye problems will aggravate the demand for these devices, fueling the market’s growth. The
Ophthalmic Lasers Market - Global Industry Analysis 2025
Ophthalmic lasers are used for treatment of wide range of eye problems. Significant accuracy, low-cost, safe procedure, and convenient ophthalmic tools has increased the demand for ophthalmic lasers. Patients prefer ophthalmic lasers treatment due to pain free procedures and easy availability on an outpatient basis. The main constituents of an ophthalmic laser system include foot pedal, laser console, and laser delivery system. The laser energy is transmitted to the patient’s eye
Ophthalmic Lasers Market- Growth Factors
The global ophthalmic lasers market is fragmented in nature, with top five vendors accounting for a modest 35.0% share in it in 2015. The market is characterized by moderate competition. However, in the foreseeable future, competition in the market is likely to heat up on the back of pharmaceutical companies entering it sensing an opportunity in the rising demand for effective surgical products because of the increasing number of ophthalmic
Excimer and Femtosecond Ophthalmic Lasers Market
Global excimer and femtosecond ophthalmic lasers market will expand at a CAGR of 5% over the forecast period, 2016-2026. The global excimer and femtosecond ophthalmic lasers market is expected to witness stable growth in 2016, reaching a value of US$ 666 Mn in terms of revenues. Excimer laser systems will continue to outsell femtosecond lasers. North America will remain the top market, whereas Asia Pacific (excluding China and Japan) is anticipated